Many Medicines Set To Be Cheaper After 5th Price Cap

KOLKATA : For the fifth consecutive time in the current year, some medicines are set to be cheaper after the National Pharmaceutical Pricing Authority (NPPA) on Tuesday capped prices of 129 drugs. A number of medicines like paracetamol have seen prices declining for the second time this year. However, prices of a few medicines like montelukast and metformin have increased.

The list of 129 drugs that NPPA came out with includes medicines like paracetamol, amoxycillin, rabeprazole and metformin. Many of these are used by patients on a regular basis. Paracetamol (650mg), which is sold for Rs 2.3 per tablet at present, is now capped at Rs 1.8 per tablet. Earlier this year, the NPPA had reduced prices of combination formulation of paracetamol. The price of amoxycillin and potassium clavulanate was also brought down from Rs 22.3 to Rs 16.8 per tablet.

The price of moxifloxacin (400mg) has also been drastically reduced to Rs 22.8 from the current Rs 31.5 per tablet. Used for treating bacterial infections like pneumonia, the price of this medicine was reduced for the first time this year. However, prices of a few medicines like metformin (500mg) were increased from Rs 1.7 to Rs 1.8 in the new list. Used in the treatment of Type II diabetes, prices of combination formulation of metformin have been changed a number of times in the past one year.

Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists (AIOCD), said: “This is a welcome move. But some medicines like paracetamol have already seen lowest prices. With the price of active pharmaceutical ingredients (API) on the rise, there is less room left for the manufacturers to curtail the prices further. I hope the supplies are not affected in the future.”

According to Sajal Ganguly, secretary of the Bengal Chemists and Druggists Association (BCDA), medicines with the new price tag will start arriving by January-end. “It normally takes a month for the medicines with new prices to arrive in the market. We should get the new stock by the end of next month,” he said.

  • Related Posts

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

    Three arrested after liquor bottles found at pharma firm

    Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    Three arrested after liquor bottles found at pharma firm

    Three arrested after liquor bottles found at pharma firm

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources